Your company account is blocked and you cannot place orders. If you have questions, please contact your company administrator.

Recombinant RUNX2 Antibody - Primary antibody, specific to RUNX2, Rabbit IgG

    Application:
  • IF/ICC
  • IHC
  • WB
Features and benefitsView More
  • Host species: Rabbit
  • Species reactivity(Reacts with): Human,Mouse,Rat
  • Isotype: Rabbit IgG
  • Conjugation: Unconjugated
Item Number
Ab126131
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab126131-10μl
10μl
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$49.90
Ab126131-50μl
50μl
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$149.90
Ab126131-100μl
100μl
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$249.90
Ab126131-1ml
1ml
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,399.90

Recombinant; Rabbit anti Human RUNX2 Antibody; WB, IHC, IF/ICC; Unconjugated

AI Insight

Basic Description

Product NameRecombinant RUNX2 Antibody - Primary antibody, specific to RUNX2, Rabbit IgG
SynonymsAML3 | CCD | Acute myeloid leukemia 3 protein | CBFA1 | CBF-alpha-1 | CCD1 | CCDAML3 | CLCD | Core-binding factor subunit alpha-1 | core-binding factor, runt domain, alpha subunit 1 | MGC120023 | ML3 | oncogene AML-3 | OSF2 | OSF-2 | osteoblast-specific t
Specifications & PurityRecombinant, ExactAb™, Validated, See COA
Biochemical and Physiological MechanismsTranscription factor involved in osteoblastic differentiation and skeletal morphogenesis. Essential for the maturation of osteoblasts and both intramembranous and endochondral ossification. CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhanc
Host speciesRabbit
SpecificityRUNX2
ImmunogenA synthetic peptide derived from human RUNX2 (AA 300-450)
Positive ControlWB: MDA-MB-231 cell lysate. IHC: Human colon, Human Hodgkin's lymphoma tissue. IF/ICC: Saos-2 cells.
ConjugationUnconjugated
GradeExactAb™, Recombinant, Validated
Product Description

Rabbit anti Human RUNX2 Antibody, Recombinant, could be used for WB, IHC, IF/ICC and so on.

Product Properties

IsotypeRabbit IgG
Light Chain Typekappa
SDS-PAGE150 kDa
Purification MethodProtein A purified
FormLiquid
ConcentrationSee COA
Storage TempStore at -20°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at 4°C short term (1-2 weeks). Store at -20°C long term (24 months). Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.

Images

Recombinant RUNX2 Antibody (Ab126131) - Western Blot
All lanes: Recombinant RUNX2 Antibody (Ab126131) at 1/1000 dilution
Samples: Lysates at 10 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/10000 dilution

Predicted band size: 57 kDa
Observed band size: 59 kDa. The RUNX2 protein, also known as Core-binding factor 1, is a transcription factor that plays a crucial role in cell differentiation and skeletal development. Transcription factors with DNA-binding motifs influence migration resulting in the generation of multiple bands.
Exposure time: 8.1 s

Recombinant RUNX2 Antibody (Ab126131) - IF/ICC
Immunofluorescent analysis of Saos-2 cells, using Recombinant RUNX2 Antibody (Ab126131).

Recombinant RUNX2 Antibody (Ab126131) - IHC
Immunohistochemical analysis of paraffin-embedded Human Hodgkin's lymphoma, using Recombinant RUNX2 Antibody (Ab126131) at 1/300 dilution. 

Recombinant RUNX2 Antibody (Ab126131) - IHC
Immunohistochemical analysis of paraffin-embedded human colon, using Recombinant RUNX2 Antibody (Ab126131).

Associated Targets(Human)

RUNX2 Tbio Runt-related transcription factor 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Application

ApplicationDilution info
IHC1/100-1/500

">

1/100-1/500

WB1/1000 - 1/2000

">

1/1000 - 1/2000

IF/ICC1/50 - 1/200

">

1/50 - 1/200

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot NumberCertificate TypeDateItem
ZJ24F0708451Certificate of AnalysisJul 17, 2024 Ab126131
ZJ24F0708450Certificate of AnalysisJul 17, 2024 Ab126131

Related Documents

Reviews

Customer Reviews

No reviews here yet. Be the first to write one!

References

1. Mundlos, S S and 13 more authors..  (1997)  Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia..  Cell,    (30):   [PMID:9182765]
2. Lee, B B and 8 more authors..  (1997)  Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia..  Nature genetics,      [PMID:9207800]
3. Zhang, Y W YW, Bae, S C SC, Takahashi, E E and Ito, Y Y..  (1997)  The cDNA cloning of the transcripts of human PEBP2alphaA/CBFA1 mapped to 6p12.3-p21.1, the locus for cleidocranial dysplasia..  Oncogene,    (17):   [PMID:9233771]
4. Geoffroy, V V, Corral, D A DA, Zhou, L L, Lee, B B and Karsenty, G G..  (1998)  Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function..  Mammalian genome : official journal of the International Mammalian Genome Society,      [PMID:9434946]
5. Xiao, Z S ZS, Thomas, R R, Hinson, T K TK and Quarles, L D LD..  (1998)  Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor..  Gene,    (3):   [PMID:9651525]
6. Quack, I I and 12 more authors..  (1999)  Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia..  American journal of human genetics,      [PMID:10521292]
7. Zhou, G G and 11 more authors..  (1999)  CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia..  Human molecular genetics,      [PMID:10545612]
8. Zhang, Y W YW and 13 more authors..  (2000)  PEBP2alphaA/CBFA1 mutations in Japanese cleidocranial dysplasia patients..  Gene,    (22):   [PMID:10689183]
9. Giannotti, A A and 7 more authors..  (2000)  A novel CBFA1 mutation (R190W) in an Italian family with cleidocranial dysplasia..  Human mutation,      [PMID:10980549]
10. Otto, Florian F, Kanegane, Hirokazu H and Mundlos, Stefan S..  (2002)  Mutations in the RUNX2 gene in patients with cleidocranial dysplasia..  Human mutation,      [PMID:11857736]
11. Pelletier, Nadine N, Champagne, Nathalie N, Stifani, Stefano S and Yang, Xiang-Jiao XJ..  (2002)  MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2..  Oncogene,    (18):   [PMID:11965546]
12. Machuca-Tzili, L L, Monroy-Jaramillo, N N, González-del Angel, A A and Kofman-Alfaro, S S..  (2002)  New mutations in the CBFA1 gene in two Mexican patients with cleidocranial dysplasia..  Clinical genetics,      [PMID:12081718]
13. Willis, David M DM and 5 more authors..  (2002)  Regulation of osteocalcin gene expression by a novel Ku antigen transcription factor complex..  The Journal of biological chemistry,    (4):   [PMID:12145306]
14. Yoshida, Taketoshi T and 6 more authors..  (2002)  Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations..  American journal of human genetics,      [PMID:12196916]
15. Morava, Eva E and 5 more authors..  (2002)  Cleidocranial dysplasia with decreased bone density and biochemical findings of hypophosphatasia..  European journal of pediatrics,      [PMID:12424590]
16. Kim, Hyo-Jin HJ and 14 more authors..  (2006)  Four novel RUNX2 mutations including a splice donor site result in the cleidocranial dysplasia phenotype..  Journal of cellular physiology,      [PMID:16270353]
17. Qiao, Meng M and 5 more authors..  (2006)  Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation..  The Journal of biological chemistry,    (17):   [PMID:16407259]
18. Ono, Masahiro M and 8 more authors..  (2007)  Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1..  Nature,    (5):   [PMID:17377532]
19. Ryoo, H-M HM, Kang, H-Y HY, Lee, S-K SK, Lee, K-E KE and Kim, J-W JW..  (2010)  RUNX2 mutations in cleidocranial dysplasia patients..  Oral diseases,      [PMID:19744171]
20. Wang, G X GX, Sun, R P RP and Song, F L FL..  (2010)  A novel RUNX2 mutation (T420I) in Chinese patients with cleidocranial dysplasia..  Genetics and molecular research : GMR,    (12):   [PMID:20082269]
21. Ott, Claus E CE and 18 more authors..  (2010)  Deletions of the RUNX2 gene are present in about 10% of individuals with cleidocranial dysplasia..  Human mutation,      [PMID:20648631]
22. Moffatt, Pierre P and 14 more authors..  (2013)  Metaphyseal dysplasia with maxillary hypoplasia and brachydactyly is caused by a duplication in RUNX2..  American journal of human genetics,    (7):   [PMID:23290074]
23. Callea, Michele M and 7 more authors..  (2014)  A case of cleidocranial dysplasia with peculiar dental features: pathogenetic role of the RUNX2 mutation and long term follow-up..  Oral health and dental management,      [PMID:24984680]
24. Zeng, Li L and 8 more authors..  (2017)  Functional analysis of novel RUNX2 mutations in cleidocranial dysplasia..  Mutagenesis,    (1):   [PMID:28505335]
25. Jung, Yu-Jin YJ, Bae, Han-Sol HS, Ryoo, Hyun-Mo HM and Baek, Seung-Hak SH..  (2018)  A novel RUNX2 mutation in exon 8, G462X, in a patient with Cleidocranial Dysplasia..  Journal of cellular biochemistry,      [PMID:28703881]
26. Zhang, Xianli X and 5 more authors..  (2017)  Analysis of novel RUNX2 mutations in Chinese patients with cleidocranial dysplasia..  PloS one,      [PMID:28738062]

Solution Calculators